author-photo

Kim Papp

University of Western Ontario

354

Papers

21477

Citations

Citation Trend

Filter By

Papers (248) Sort By

Journal Conference Others

P171 Efficacy and safety of upadacitinib in patients with active PsA and inadequate response to biologic DMARDs (SELECT-PsA-2): a double-blind, randomised controlled Phase III trial

2021 Rheumatology
Show All
- Source
- Cite
- Save
Citations (0)
Response to Reader Comment on "Efficacy of Brodalumab for Moderate to Severe Plaque Psoriasis: A Canadian Network Meta-Analysis".

2021 Journal of Cutaneous Medicine and Surgery
Show All
- Source
- Cite
- Save
Citations (0)
Dermatologists' Perspectives on Defining Moderate Psoriasis: The Canadian Moderate Psoriasis Survey.

2021 Journal of Drugs in Dermatology
Show All
- Source
- Cite
- Save
Citations (0)
Once-Daily Roflumilast Cream 0.3%, a Potent Phosphodiesterase-4 Inhibitor, Provided Safe and Effective Treatment of Psoriasis in the DERMIS-1 and DERMIS-2 Phase 3 Trials

2021
Show All
- Source
- Cite
- Save
Citations (0)
Bimekizumab versus Adalimumab in Plaque Psoriasis.

2021 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (13)
Itch-Free State in Patients With Atopic Dermatitis Treated With Ruxolitinib Cream

2021
Show All
- Source
- Cite
- Save
Citations (0)
313 Itch-free state in patients with atopic dermatitis treated with ruxolitinib cream

2021 Journal of Investigative Dermatology
Show All
- Source
- Cite
- Save
Citations (0)
Psoriasis Prevalence and Severity by Expert Elicitation.

2021 Dermatologic Therapy
Show All
- Source
- Cite
- Save
Citations (1)
Signal Detection and Methodological Limitations in a Real-World Registry: Learnings from the Evaluation of Long-Term Safety Analyses in PSOLAR.

2021 Drug Safety
Show All
- Source
- Cite
- Save
Citations (0)
Upadacitinib in Patients with Psoriatic Arthritis and Inadequate Response to Biologics: 56-Week Data from the Randomized Controlled Phase 3 SELECT-PsA 2 Study.

2021
Show All
- Source
- Cite
- Save
Citations (2)